{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:41:46Z","timestamp":1707266506698},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00393-023-01444-0","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:02:51Z","timestamp":1699574571000},"page":"28-33","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GKJR(Gesellschaft f\u00fcr Kinder- und Jugendrheumatologie)-Diagnose- und Therapieoptimierungsboard \u2013\u00a0neue Wege zu Diagnose und Therapie komplexer Erkrankungen","Society for Pediatric and Adolescent Rheumatology (GKJR) diagnosis and treatment optimization board\u2014New ways to the diagnosis and treatment of complex diseases"],"prefix":"10.1007","volume":"83","author":[{"given":"Toni","family":"Hospach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilmann","family":"Kallinich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Rietschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Hufnagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Freudenhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"R\u00fccklov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasad T.","family":"Oommen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"issue":"2","key":"1444_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.berh.2014.05.001","volume":"28","author":"MJ Ombrello","year":"2014","unstructured":"Ombrello\u00a0MJ, Sikora\u00a0KA, Kastner\u00a0D (2014) Genetic, genomics and their relevance to pathology and therapy. Best Pract Res Clin Rheumatol 28(2):175\u2013189 (Apr)","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"1444_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/acr.24853","volume":"74","author":"KB Onel","year":"2021","unstructured":"Onel\u00a0KB, Horton\u00a0DB, Lovell\u00a0DB et\u00a0al (2021) American College of Rheumatology guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for oligoarthritis, temporomandibular joint arthritis, and systemic juvenile idiopathic arthritis. Arthritis Care Res (hoboken) 74(4):521\u2013537 (2022 Apr)","journal-title":"Arthritis Care Res (hoboken)"},{"key":"1444_CR3","doi-asserted-by":"publisher","first-page":"109143","DOI":"10.1016\/j.clim.2022.109143","volume":"245","author":"PT Oommen","year":"2022","unstructured":"Oommen\u00a0PT, Strauss\u00a0T, Baltruschat\u00a0B et al (2022) Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German society of pediatric and juvenile rheumatic diseases (GKJR): new perspectives on interdisciplinary care. Clin Immunol 245:109143","journal-title":"Clin Immunol"},{"issue":"12","key":"1444_CR4","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg\u00a0IE, Tj\u00e4rnlund\u00a0A, Bottai\u00a0M, Werth\u00a0VP, Pilkington\u00a0C, de Visser\u00a0M et\u00a0al (2017) European league against rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76(12):1955\u20131964","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1444_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41531-022-00421-9","volume":"8","author":"B Labeit","year":"2022","unstructured":"Labeit\u00a0B, Berkovich\u00a0E, Claus\u00a0I, Roderigo\u00a0M, Schwake\u00a0AL, Izgelov\u00a0D et\u00a0al (2022) Dysphagia for medication in Parkinson\u2019s disease. Npj Park Dis 8(1):156 (Nov;12;)","journal-title":"Npj Park Dis"},{"key":"1444_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3389\/fneur.2019.00739","volume":"10","author":"B Labeit","year":"2019","unstructured":"Labeit\u00a0B, Muhle\u00a0P, Suntrup-Krueger\u00a0S, Ahring\u00a0S, Ruck\u00a0T et al (2019) Dysphagia as isolated manifestation of Jo\u20111 associated myositis. Front Neurol 10:739 (Jul;9)","journal-title":"Front Neurol"},{"issue":"1","key":"1444_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/cells11010109","volume":"30;11","author":"A Sch\u00e4nzer","year":"2021","unstructured":"Sch\u00e4nzer\u00a0A, Rager\u00a0L, Dahlhaus\u00a0I, Dittmayer\u00a0C, Preusse\u00a0C, Marina\u00a0DA et\u00a0al (2021) Morphological characteristics of idiopathic inflammatory myopathies in juvenile patients. Cells 30;11(1):109 (Dec)","journal-title":"Cells"},{"issue":"11","key":"1444_CR8","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1093\/rheumatology\/keab152","volume":"60","author":"MG Lazzaroni","year":"2021","unstructured":"Lazzaroni\u00a0MG, Marasco\u00a0E, Campochiaro\u00a0C, De-Vries-Bouwstra\u00a0J, Gonzalez-Perez\u00a0MI, Rojas-Serrano\u00a0J et al (2021) The clinical phenotype of systemic sclerosis patients with anti-PM\/Scl antibodies: results from the EUSTAR cohort. Rheumatol 60(11):5028\u20135041 (Nov;3)","journal-title":"Rheumatol"},{"issue":"6","key":"1444_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/BF01451281","volume":"17","author":"S Jablonska","year":"1998","unstructured":"Jablonska\u00a0S, Scleromyositis\u00a0BM (1998) a\u00a0scleroderma\/polymyositis overlap syndrome. Clin Rheumatol 17(6):465\u2013467","journal-title":"Clin Rheumatol"},{"key":"1444_CR10","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.autrev.2017.10.005","volume":"16","author":"C Durtette","year":"2017","unstructured":"Durtette\u00a0C, Hachulla\u00a0E, Resche-Rigon\u00a0M, Papo\u00a0T, Z\u00e9none\u00a0T, Lioger\u00a0B et al (2017) Cogan syndrome: Characteristics, outcome and treatment in a\u00a0French nationwide retrospective study and literature review. Autoimmun Rev 16:1219\u20131223","journal-title":"Autoimmun Rev"},{"issue":"11","key":"1444_CR11","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1093\/annonc\/mdx484","volume":"28","author":"JY Blay","year":"2017","unstructured":"Blay\u00a0JY, Soibiniet\u00a0P, Penel\u00a0N, Bompas\u00a0E, Duffaud\u00a0F, Stoeckle\u00a0E et\u00a0al (2017) Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol 28(11):2852\u20132859 (Nov)","journal-title":"Ann Oncol"},{"issue":"12","key":"1444_CR12","doi-asserted-by":"publisher","first-page":"e27384","DOI":"10.1002\/pbc.27384","volume":"65","author":"J Kreyer","year":"2018","unstructured":"Kreyer\u00a0J, Ranft\u00a0A, Timmermann\u00a0B, Joergens\u00a0H, Jung\u00a0S, Wiebe\u00a0K et\u00a0al (2018) Impact of the interdisciplinary tumor board oft he cooperative ewing sarcoma study group on local therapy and overall survival of ewing sarcoma patients after induction therapy. Pediatr Blood Cancer 65(12):e27384 (Dec)","journal-title":"Pediatr Blood Cancer"},{"key":"1444_CR13","unstructured":"Richtlinie des Gemeinsamen Bundesausschusses \u00fcber Ma\u00dfnahmen zur Qualit\u00e4tssicherung f\u00fcr die station\u00e4re Versorgung von Kindern und Jugendlichen mit h\u00e4mato-onkologischen Krankheiten gem\u00e4\u00df \u00a7\u00a0136 Abs.\u00a01 Satz\u00a01, Nr 2 SGB\u00a0V nach \u00a7\u00a0108 SGB\u00a0V zugelassene Krankenh\u00e4user; zuletzt ge\u00e4ndert am 2. November 2022, in Kraft getreten am 1.\u00a0Januar 2023"},{"key":"1444_CR14","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1056\/NEJMp2003539","volume":"382","author":"JE Hollander","year":"2020","unstructured":"Hollander\u00a0JE, Carr\u00a0BG (2020) Virtually perfect? Telemedicine for covid-19. N\u00a0Engl J Med 382:1679\u20131681","journal-title":"N Engl J Med"},{"key":"1444_CR15","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","volume":"75","author":"K Mariampillai","year":"2018","unstructured":"Mariampillai\u00a0K et al (2018) Development of a\u00a0new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies. JAMA Neurol 75:1528\u20131537. https:\/\/doi.org\/10.1001\/jamaneurol.2018.2598","journal-title":"JAMA Neurol"},{"key":"1444_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","volume":"16","author":"Y Allenbach","year":"2020","unstructured":"Allenbach\u00a0Y, Benveniste\u00a0O, Stenzel\u00a0W, Boyer\u00a0O (2020) Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol 16:689\u2013701. https:\/\/doi.org\/10.1038\/s41584-020-00515-9","journal-title":"Nat Rev Rheumatol"},{"key":"1444_CR17","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1007\/s10067-019-04710-2","volume":"38","author":"C Soubrier","year":"2019","unstructured":"Soubrier\u00a0C et al (2019) Nailfold videocapillaroscopy alterations in dermatomyositis, antisynthetase syndrome, overlap myositis, and immune-mediated necrotizing myopathy. Clin Rheumatol 38:3451\u20133458. https:\/\/doi.org\/10.1007\/s10067-019-04710-2","journal-title":"Clin Rheumatol"},{"key":"1444_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","volume":"28","author":"Y Allenbach","year":"2018","unstructured":"Allenbach\u00a0Y, Mammen\u00a0AL, Benveniste\u00a0O, Stenzel\u00a0W, Immune-Mediated Necrotizing Myopathies Working (2018) 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316\u00a0October 2016. Neuromuscul Disord 28:87\u201399. https:\/\/doi.org\/10.1016\/j.nmd.2017.09.016","journal-title":"Neuromuscul Disord"},{"key":"1444_CR19","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00393-019-0665-0","volume":"78","author":"J Bauhammer","year":"2019","unstructured":"Bauhammer\u00a0J, Fien\u00a0C (2019) Antisynthetasesyndrome. Z\u00a0Rheumatol 78:645\u2013655","journal-title":"Z Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-023-01444-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-023-01444-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-023-01444-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T13:04:03Z","timestamp":1707224643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-023-01444-0"}},"subtitle":["Eine Analyse nach 2\u00a0Jahren Praxistest","An analysis after 2\u00a0years testing in practice"],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1444"],"URL":"https:\/\/doi.org\/10.1007\/s00393-023-01444-0","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]},"assertion":[{"value":"29 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Hospach, T.\u00a0Kallinich, C.\u00a0Rietschel, M.\u00a0Hufnagel, J.\u00a0Freudenhammer, K.\u00a0R\u00fccklov\u00e1 und P.T.\u00a0Oommen geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}